USPTO serial 79216156
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Deadline: June 16th, 2026
Mapix S.à.r.l.
LU
Mapix S.à.r.l
LU
Mapix S.à.r.l
LU
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Sanitary preparations for medical purposes; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses, namely, varicella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirus, rotavirus, coronavirus, adenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, respiratory viruses; antibody-based pharmaceutical preparations for the treatment of infection diseases; antibody-based pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses (varicella, infectious mononucleosis); antibody-based pharmaceutical preparations for the prevention and treatment of enterovirus, rotavirus, coronaviruses, adenoviral diseases; antibody-based pharmaceutical preparations to prevent and treat diseases caused by tick-borne encephalitis virus, calicivirus, espiratory viruses; pharmaceutical preparations for the treatment of AIDS/HIV infection; antibody-based pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations for the treatment of viral hepatitis; antibody-based pharmaceutical preparations for the treatment of viral hepatitis; pharmaceutical preparations for the treatment of influenza; antibody-based pharmaceutical preparations for the treatment of influenza; disinfectants for hygiene purposes, including disinfectants fighting microorganisms which cause infectious disease in man; immunomodulators; anti-mutagenic pharmaceutical preparations for the prevention and treatment of infection diseases | ACTIVE | — |
| Date | Code | Event |
|---|---|---|
| Jun 16, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Nov 1, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Oct 14, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB |
| Oct 3, 2020 | FIMP | FINAL DISPOSITION PROCESSED |
| Sep 16, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Jun 16, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER |
| May 8, 2020 | TMBN | TTAB RELEASE CASE TO TRADEMARKS |
| May 8, 2020 | OP.T | OPPOSITION TERMINATED NO. 999999 |
| May 8, 2020 | OP.D | OPPOSITION DISMISSED NO. 999999 |
| Apr 22, 2020 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| Apr 2, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB |
| Mar 1, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Feb 13, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Feb 13, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Jun 8, 2018 | RFNT | REFUSAL PROCESSED BY IB |
| May 17, 2018 | OP.I | OPPOSITION INSTITUTED NO. 999999 |
| May 16, 2018 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
| May 16, 2018 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED |
| May 4, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Feb 13, 2018 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Feb 3, 2018 | GPNX | NOTIFICATION PROCESSED BY IB |
| Jan 16, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 16, 2018 | PUBO | PUBLISHED FOR OPPOSITION |
| Dec 27, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Dec 27, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Dec 27, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 4, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 1, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Nov 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Nov 30, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Oct 18, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Oct 14, 2017 | RFNT | REFUSAL PROCESSED BY IB |
| Sep 25, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sep 25, 2017 | RFRR | REFUSAL PROCESSED BY MPU |
| Sep 20, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sep 19, 2017 | CNRT | NON-FINAL ACTION WRITTEN |
| Sep 19, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Sep 13, 2017 | DOCK | ASSIGNED TO EXAMINER |
| Sep 13, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 7, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB |